Viridian Therapeutics, Inc.\DE Cash Flow Statement

Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -2.16M-7.89M-11.33M-17.31M-26.91M-33.96M-42.81M-110.89M-79.41M-129.87M-237.73M-269.95M
Share-based Compensation 4.30M3.02M0.28M2.41M3.68M3.97M6.00M14.46M19.77M67.17M42.15M
Cash from Discontinued Operations -0.19M
Gains from Sales and Divestitures 0.28M0.46M0.05M
Gains from Investment Securities 0.15M0.04M0.07M-0.00M-0.04M-0.08M-0.03M0.50M
Asset Writedowns and Impairment 0.18M0.80M
Non-cash Items 0.39M0.08M0.04M
Cash from Operations -1.17M-2.21M-6.90M-14.76M-28.17M-26.84M-36.06M-29.78M-54.58M-93.84M-184.17M-232.32M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.16M0.09M0.42M0.43M0.26M-0.96M0.21M11.49M15.65M
Amortization of Deferred Charges 1.94M1.01M0.13M0.09M0.28M0.09M0.23M0.32M0.38M
Depreciation & Amortization (CF) 0.15M0.14M0.18M0.34M0.31M0.30M0.30M0.24M0.12M0.30M0.52M0.54M
Change in Working Capital
Change in Receivables -0.20M0.09M-0.69M0.02M1.44M-1.43M0.08M-0.10M
Change in Inventory 0.19M-0.18M0.01M-0.12M
Change in Account Payables 0.29M-0.10M-0.34M0.53M-0.43M1.66M11.52M-12.04M-0.07M
Change in Accured Expenses -0.28M0.38M0.63M2.21M-2.21M0.79M1.08M5.01M1.38M7.72M5.01M21.62M
Investing Activities
Capital Expenditures 0.01M0.27M0.12M0.25M0.25M0.45M0.08M0.04M0.34M0.80M0.90M0.51M
Sales of Property, Plant and Equipment 0.08M
Acquisitions 1.28M29.37M
Change in Acquisitions & Divestments 1.00M33.00M61.00M2.00M114.40M108.94M314.53M466.93M
Cash from Investing Activities 0.01M-0.27M-0.10M-0.25M1.03M-29.91M28.23M-50.48M-74.29M-115.13M-94.25M-228.65M
Financing Activities
Other financing activities 0.01M-0.01M0.05M0.09M1.22M3.04M4.88M0.45M
Debt Issuance and Repayment
Long-Term Debt Issuances 12.57M0.80M10.00M1.73M5.00M15.00M
Long-Term Debt Repayments 0.06M0.04M0.08M0.33M4.67M2.33M10.29M
Change in Capital Stock
Shares Issued -0.50M6.64M13.10M0.21M0.31M44.53M2.48M114.24M291.87M125.07M453.66M
Shares Repurchased 27.33M0.00M
Preferred Shares Issued 16.09M91.00M16.96M44.00M25.00M
Dividend Payments
Dividends Paid - Common 0.28M
Misc.
Cash from Financing Activities 1.26M7.40M12.71M15.87M52.47M41.92M0.07M101.31M125.28M322.24M225.67M457.74M
Change in Cash 0.10M4.91M5.71M0.87M25.34M-14.84M-7.76M21.05M-3.60M113.28M-52.75M-3.23M
Beginning Cash Balance 10.46M
Free Cash Flow -1.17M-2.48M-7.02M-15.01M-28.41M-27.29M-36.14M-29.82M-54.92M-94.64M-185.07M-232.83M
Net Cash Flow 0.10M4.91M5.71M0.87M25.34M-14.84M-7.76M21.05M-3.60M113.28M-52.75M-3.23M